Please login to your online account to display your discounted pricing

Promega™ Riboprobe™ Systems

For in vitro prepartion of high specific activity single-stranded RNA probes or microgram quantities of defined RNA transcripts from cloned DNA inserts

$212.93 - $212.93

Specifications

For Use With (Application) Generation of high-specific-activity RNA probes, generation of microgram quantities of RNA transcripts, generation of RNA processing substrates, generation of antisense RNA
Storage Requirements Store at -20°C.
View More Specs
Includes:  RNA polymerase(s); pGEM™ Express Positive Control Template; RQ1 RNase-free DNase; Recombinant RNasin™ Ribonuclease Inhibitor; rATP; rCTP; rGTP; rUTP; DTT; Transcription-optimized buffer, 5X; Nuclease-free water
Products
Catalog Number Mfr. No. Includes Price Quantity    

PR-P1440

 
promega™
P1440
500U RNA Polymerase (T7), 5μg pGEM™ express positive control template, 500μL transcription optimized 5X Buffer, 2500U recombinant RNasin™ RNase inhibitor, 100mM 100 Each for $212.93

PR-P1420

 
promega™
P1420
500U RNA Polymerase (SP6), 5μg pGEM™ express positive control template, 500μL transcription optimized 5X Buffer, 2500U recombinant RNasin™ RNase inhibitor, 100mM 100 Each for $212.93

PR-P1430

 
promega™
P1430
500U RNA Polymerase (T3), 5μg pGEM™ express positive control template, 500μL transcription optimized 5X Buffer, 2500U recombinant RNasin™ RNase inhibitor, 100mM 100 Each for $212.93
Description & Specifications

Specifications

For Use With (Application) Generation of high-specific-activity RNA probes, generation of microgram quantities of RNA transcripts, generation of RNA processing substrates, generation of antisense RNA
Storage Requirements Store at -20°C.

  • All required reagents (excluding radioisotope) for performing transcription reactions in vitro and DNase to remove the template following transcription are included
  • SP6, T7 and T3 RNA Polymerases are extremely promoter-specific, allowing production of virtually homogeneous RNA using plasmid DNA as a template

U.S. Patent 5,552,302; Australian Patent 646803 and other patents.
Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.